REVIMMUNE
Dead / Abandoned — Abandoned — no statement of use filed (as of 11 Jul 2022)
What this means for you
This application is over — abandoned 11 Jul 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88198822
- Mark type
- Stylized text
- Filed
- 19 Nov 2018
- Published for opposition
- 09 Apr 2019
- Abandoned
- 11 Jul 2022
- Attorney of record
- Keith W. Medansky
Goods and services
- Class 005 — Pharmaceuticals: Biological and pharmaceutical preparations, namely, biological and pharmaceutical preparations and substances for the prevention and treatment of blood disease and cancer, viral and other infectious diseases, and the modulation and treatment of immune system related diseases and disorders
Owner
- RevImmune, Inc., Bethesda, MD, US
- RevImmune, Inc., Bethesda, MD, US
Prosecution history
- 11 Jul 2022 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 11 Jul 2022 — ABANDONMENT - NO USE STATEMENT FILED
- 09 Dec 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Dec 2021 — CORRECTED NOA E-MAILED
- 08 Dec 2021 — SOU EXTENSION 5 GRANTED
- 24 Nov 2021 — SOU EXTENSION 5 FILED
- 08 Dec 2021 — DIVISIONAL PROCESSING COMPLETE
- 29 Nov 2021 — DIVISIONAL REQUEST RECEIVED
- 08 Dec 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 29 Nov 2021 — TEAS REQUEST TO DIVIDE RECEIVED
- 24 Nov 2021 — SOU TEAS EXTENSION RECEIVED
- 27 May 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 May 2021 — SOU EXTENSION 4 GRANTED
- 25 May 2021 — SOU EXTENSION 4 FILED
- 25 May 2021 — SOU TEAS EXTENSION RECEIVED